Key result
Intramuscular methylergonovine administered for postpartum hemorrhage caused severe coronary vasospasm leading to myocardial ischemia, evidenced by chest pain and troponin elevation.
Population
A 29-year-old female with history of smoking and idiopathic thrombocytopenia receiving postpartum methylergonovine
Design
Case report
Authors
Loading...
Alerts clinicians to rare methylergonovine-induced vasospasm in peripartum patients; case report leaves open questions on incidence and risk factors.
Case Report (n=1)
Intramuscular methylergonovine, a first-line agent for postpartum hemorrhage, can rarely cause severe coronary vasospasm and myocardial ischemia, requiring prompt recognition and management.
Jang et al. (2023) conducted a case report in Post-partum myocardial ischemia (n=1). Intramuscular methylergonovine was evaluated on Coronary vasospasm and myocardial ischemia. Intramuscular methylergonovine administered for postpartum hemorrhage caused severe coronary vasospasm leading to myocardial ischemia, evidenced by chest pain and troponin elevation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: